Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

尼欣那 - NMPA Drug Approval Details

Approvals/NMPA/Alogliptin Benzoate Tablets

Approved

化学药品

Alogliptin Benzoate Tablets

TAKEDA PHARMACEUTICAL COMPANY LIMITED🇨🇳 National Medical Products Administration

Approval Date: Oct 30, 2023
Approval ID: 8VIZ95Za0KO
Company: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Type: 化学药品

Approval Details

Approval Id: 8VIZ95Za0KO
Approval Number: 国药准字HJ20130548
Generic Name: 苯甲酸阿格列汀片
Generic Name En: Alogliptin Benzoate Tablets
Trade Name: 尼欣那
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 按C₁₈H₂₁N₅O₂计, 25mg
Reg Date: 2023-10-30
Expired Date: 2028-10-29
Company Name: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Production Company Name: TAKEDA IRELAND LIMITED
Company Detail Path: /organization/takeda-pharmaceutical-company-limited
Production Company Detail Path: /organization/takeda-ireland-limited

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 30, 2023

Approval ID

8VIZ95Za0KO

Type

化学药品

Back to NMPA Approvals